rapid
evolut
rna
virus
repres
signific
challeng
prevent
treat
erad
rna
viral
diseas
high
mutat
rate
rna
virus
gener
extens
opportun
overcom
evolutionari
hurdl
antivir
drug
host
immun
engin
attenu
chang
evolutionari
pathway
travers
rna
virus
shape
natur
select
favor
evolutionari
trajectori
other
base
whether
mutat
benefici
deleteri
neutral
predict
like
result
rna
viru
evolut
import
step
anticip
viral
emerg
develop
escaperesist
antivir
drug
vaccin
coronavirus
cov
famili
positivesens
rna
virus
caus
human
ill
rang
common
cold
sever
lethal
respiratori
diseas
cov
encod
proofread
exoribonucleas
within
nonstructur
protein
critic
replic
fidel
fit
virul
exon
inactiv
propos
strategi
live
attenu
vaccin
develop
member
deddh
superfamili
exonucleas
cov
exon
hydrolyz
nucleotid
use
four
metalcoordin
amino
acid
arrang
three
motif
de
ii
e
iii
alanin
substitut
exon
motif
detoaa
disrupt
exon
biochem
activ
sever
acut
respiratori
syndrom
sar
cov
human
cov
betacoronavirus
murin
hepat
viru
mhv
sarscov
toler
disrupt
exon
activ
exon
display
mutat
phenotyp
accompani
defect
replic
competit
fit
evas
innat
immun
respons
exon
activesit
mutant
alphacoronavirus
includ
transmiss
gastroenter
viru
yet
recov
propos
lethal
replic
given
critic
role
exon
cov
biolog
elev
mutat
rate
expect
natur
select
would
repeatedli
drive
revers
exoninactiv
substitut
line
expect
exon
motif
iii
mutant
sarscov
mhv
rapidli
repeatedli
revert
also
unpublish
observ
contrast
never
detect
partial
complet
revers
exon
motif
mutant
exonaa
sarscov
mhv
year
studi
hundr
experi
specif
detect
consensu
minor
variant
kind
motif
aa
codon
either
viru
strain
acut
infect
prolong
passag
tissu
cultur
follow
treatment
multipl
nucleosid
analogu
sarscovexonaa
also
stabl
acut
persist
anim
infect
immunocompet
immunocompromis
mice
lack
primari
revers
due
simpli
reduc
adapt
capac
sarscovexonaa
mhvexonaa
adapt
increas
replic
strikingli
longterm
passag
mhvexonaa
passag
yield
highli
fit
popul
directli
compens
defect
proofread
evolut
like
highfidel
rnadepend
rna
polymeras
rdrp
yet
primari
revers
would
requir
four
total
consensu
mutat
contain
studi
sought
determin
whether
specif
genet
fit
barrier
prevent
primari
revers
exon
motif
aa
end
identifi
engin
viabl
genet
pathway
toward
exonaa
motif
revers
mhv
exonaa
result
show
partial
revers
confer
select
advantag
exonaa
exonaa
adapt
within
passag
greater
fit
intermedi
revert
final
restor
wildtyp
wt
exond
set
passageselect
mutat
rdrp
exact
profound
fit
cost
togeth
data
first
observ
exon
cov
genotyp
fit
landscap
identifi
multipl
genet
barrier
underli
exon
motif
stabil
mhv
suggest
extens
coevolut
mhv
replicas
protein
adapt
reveal
potenti
strategi
stabil
exon
mutant
cov
articl
submit
onlin
preprint
archiv
mhvexon
exonaa
contain
two
engin
substitut
codon
motif
complet
revers
wtexond
requir
mutat
four
site
fig
viral
mutat
rate
absenc
proofread
rang
mutat
per
nucleotid
per
round
replic
assum
exonaa
mutat
rate
account
codon
degeneraci
probabl
restor
nativ
amino
acid
sequenc
singl
round
replic
rare
exonaa
titer
exceed
pfuml
unlik
exonaa
could
navig
genet
barrier
singl
infecti
cycl
thu
hypothes
exonaa
revers
possibl
would
proceed
increment
identifi
potenti
pathway
toward
exonaa
revers
examin
possibl
singlenucleotid
substitut
surround
fig
three
mutat
synonym
five
mutat
yield
amino
acid
unlik
coordin
posit
charg
metal
requir
exon
catalysi
glycin
valin
prolin
threonin
serin
one
mutat
per
site
restor
acid
charg
ie
aato
nativ
amino
acid
variant
test
cov
exon
biochem
studi
escherichia
coli
dna
polymeras
exon
mutant
suggest
conserv
substitut
would
restor
wtlike
exon
activ
predict
stepwis
pathway
revers
base
restor
acid
charg
follow
revers
nativ
amino
acid
fig
engin
recov
variant
exonaa
requir
three
mutat
nucleotid
nt
exonad
exonea
two
mutat
nt
exonda
exon
exona
one
mutat
nt
exondd
exone
revers
wtexond
tabl
refer
mutant
intermedi
revert
intermedi
revert
gener
viabl
progeni
recoveri
demonstr
revers
wtexond
along
pathway
theoret
possibl
mutant
genet
stabl
recoveri
confirm
dideoxi
sequenc
howev
mutant
exondd
exone
revert
wtexond
three
independ
recoveri
attempt
suggest
two
variant
less
fit
wtexond
demonstr
revers
mutat
readili
access
test
whether
mutant
would
revert
rapidli
exonaa
nt
passag
three
lineag
mutant
time
multipl
infect
moi
pfucel
harvest
supernat
screen
revers
visual
inspect
plaqu
phenotyp
passag
wtexond
wtlike
virus
produc
uniform
larg
plaqu
exonaalik
virus
yield
small
variabl
size
plaqu
observ
mix
plaqu
phenotyp
sequenc
three
larg
plaqu
lineag
confirm
revers
exonad
exonea
exonda
exon
intermedi
revert
show
evid
revers
passag
either
moi
tabl
contrast
exona
contain
wt
revert
lineag
moi
pfucel
one
lineag
moi
pfucel
observ
wt
revert
domin
exona
popul
remain
passag
data
indic
least
one
mutat
pathway
lead
full
revers
tissu
cultur
probabl
exona
aris
singl
infecti
cycl
exonaa
low
theoret
achiev
exonaa
could
conceiv
revert
within
two
infecti
cycl
howev
complet
revers
never
observ
even
prolong
passag
persist
infect
suggest
addit
barrier
replic
fit
mainten
intermedi
revert
exist
intermedi
revert
viabl
recombin
found
exonaa
popul
hypothes
confer
select
advantag
exonaa
test
hypothesi
first
analyz
replic
intermedi
revert
fig
variant
achiev
peak
titer
similar
titer
exonaa
detail
examin
kinet
suggest
potenti
delay
h
intermedi
revert
compar
kinet
exonaa
note
exona
delay
detect
wtexond
revert
two
three
replic
suggest
increas
select
pressur
variant
next
measur
competit
fit
intermedi
revert
rel
recombin
exonaa
contain
seven
silent
mutat
code
region
exonaarefer
intermedi
revert
mix
equal
titer
exonaarefer
combin
moi
pfucel
passag
four
time
ratio
intermedi
revert
exonaarefer
quantifi
passag
revers
transcriptionquantit
pcr
rtqpcr
chang
ratio
time
use
calcul
rel
fit
level
wtexond
significantli
fit
exonaa
wherea
intermedi
revert
exonad
ea
da
ed
increas
fit
rel
exonaa
fig
appar
increas
fit
exona
result
lineag
revert
wtexond
experi
final
previou
studi
shown
adapt
exonaa
includ
partial
compens
replic
fidel
defect
measur
reduc
suscept
mutagen
none
intermedi
variant
demonstr
statist
signific
differ
sensit
compar
exonaa
fig
thu
except
revert
intermedi
genotyp
along
predict
pathway
demonstr
advantag
replic
fit
fidel
would
favor
mainten
expans
viral
popul
thu
natur
select
unlik
drive
exonaa
pathway
toward
revers
although
find
fit
advantag
intermedi
revert
also
identifi
profound
fit
cost
would
drive
immedi
loss
popul
previous
demonstr
passag
exonaa
adapt
increas
replic
fit
fidel
via
secondari
mutat
outsid
motif
test
whether
secondari
adapt
mutat
could
exceed
fit
exonaa
intermedi
revert
examin
earli
adapt
exonaa
studi
passag
passag
seri
fig
retain
exonaa
motif
genotyp
increas
replic
reduc
suscept
altogeth
manifest
greater
rel
fit
fig
identifi
six
total
mutat
within
dideoxi
sequenc
tabl
indic
rapid
adapt
compens
exonaa
requir
rel
genet
chang
consensu
level
test
whether
interact
multipl
mutat
popul
level
effect
contribut
fit
isol
plaquepurifi
clone
clone
replic
higher
titer
popul
ident
sensit
rel
fit
level
fig
indic
genom
deriv
singl
viru
plaqu
encod
adapt
chang
requir
total
popul
togeth
data
demonstr
mutat
outsid
exon
motif
confer
greater
fit
advantag
intermedi
revert
even
earli
passag
earli
adapt
mutat
like
reduc
select
pressur
motif
revers
place
intermedi
revert
select
disadvantag
mutat
fit
effect
highli
depend
upon
genet
background
addit
reduc
select
pressur
revers
mutat
confer
increas
fit
exonaa
might
also
reduc
benefit
motif
revers
previous
report
longterm
passag
exonaa
select
secondari
adapt
mutat
rdrp
contain
seven
nonsynonym
mutat
partial
compens
defect
proofread
increas
exonaa
fit
contain
six
nonsynonym
mutat
includ
conserv
dtoe
substitut
exon
motif
iii
increas
exonaa
fit
without
compens
defect
proofread
test
whether
fit
effect
passageassoci
mutat
depend
upon
exonaa
genotyp
engin
wt
motif
exond
virus
contain
alon
togeth
analyz
replic
sensit
competit
fit
compar
wtexond
display
delay
decreas
replic
fig
sensit
assay
indistinguish
wtexond
variant
contain
significantli
sensit
fig
final
mutat
significantli
decreas
fit
rel
wtexond
fig
detect
statist
differ
specif
infect
wtexond
variant
isol
infect
fig
thu
mutat
aros
exonaa
background
detriment
replic
mutagen
sensit
competit
fit
presenc
fulli
revert
exond
result
support
conclus
adapt
pathway
avail
exonaa
may
stabil
exonaa
genotyp
reduc
select
pressur
potenti
benefit
primari
revers
studi
demonstr
stabil
exon
motif
genotyp
mhv
exonaa
consequ
limit
opportun
genet
landscap
explor
replic
fig
result
support
model
viabl
adapt
pathway
lead
direct
revers
motif
aa
de
rel
flat
fit
landscap
intermedi
revert
remain
phenotyp
exon
confer
fit
advantag
exonaa
contrast
least
one
altern
adapt
pathway
readili
access
impart
immedi
fit
gain
exonaa
propos
even
minim
altern
pathwayadapt
fit
gain
reduc
likelihood
benefit
motif
revers
eventu
chang
genet
background
render
revers
detriment
data
model
suggest
select
replic
favor
immedi
increment
fit
gain
along
access
pathway
rather
dramat
fit
increas
across
larger
genet
barrier
studi
focus
issu
primari
exonaa
revers
rais
intrigu
question
remain
topographi
exonaa
fit
landscap
ongo
studi
laboratori
determin
whether
repres
conserv
pathway
compens
defect
proofread
cov
genom
accommod
multipl
solut
exon
associ
debilit
support
possibl
limit
potenti
pathway
recent
studi
vaccinederiv
poliovirus
determin
evolut
virul
parallel
epidem
proceed
limit
set
genet
chang
rather
plethora
distinct
trajectori
key
find
studi
mutat
compens
exonaa
detriment
wtexond
yet
mechan
underli
dispar
clear
expect
compensatori
mutat
would
hobbl
wtexond
induc
structur
chang
activ
site
howev
replic
fit
defect
observ
exond
virus
contain
associ
alter
proofread
measur
sensit
fig
fact
mutat
substanti
affect
sensit
either
exonaa
wtexond
background
suggest
mutat
enhanc
stage
mhv
replic
cycl
perhap
interact
replicas
protein
viral
rna
result
impli
protein
mhv
replic
holoenzym
must
evolv
highli
cooper
manner
compens
defect
proofread
also
maintain
intric
intim
function
relationship
line
hypothesi
like
highfidel
disrupt
replic
resist
fit
presenc
intact
exond
catalyt
motif
given
invers
relationship
polymeras
fidel
replic
speed
slower
polymeras
proce
time
discrimin
incom
nucleotid
could
fractur
delic
kinet
balanc
polymer
excis
replic
support
hypothesi
come
recent
studi
establish
replic
lower
fidel
rdrp
dengu
viru
observ
like
highfidel
rdrp
variant
delay
replic
proofreadingcap
mhv
mutat
could
addit
effect
rdrp
function
proteinprotein
interact
incompat
activ
exon
domain
final
possibl
adapt
mutat
includ
synonym
chang
could
modifi
rna
sequenc
featur
secondari
structur
way
interfer
wtexond
defin
molecular
interact
underli
strain
specif
exonaacompensatori
mutat
use
recombin
virus
reconstitut
biochem
system
provid
uniqu
opportun
explor
complex
evolutionari
function
relationship
underpin
coronaviru
replic
machineri
result
also
extend
exist
studi
cov
exon
motif
motif
mutat
sarscov
dramat
reduc
nucleas
activ
biochem
assay
studi
examin
contribut
residu
independ
exclud
possibl
intermedi
revert
exonaa
retain
level
nucleolyt
activ
lack
consist
statist
differ
replic
sensit
competit
fit
rel
level
exonaa
support
previou
studi
demonstr
motif
de
essenti
exon
function
given
result
surpris
observ
repeat
revers
exona
two
variant
exonda
exon
one
potenti
explan
specif
mutat
bia
exona
make
revert
mutat
access
exonda
exon
altern
exona
profound
replic
fit
defect
select
could
drive
primari
revers
quickli
away
genotyp
consist
hypothesi
exona
revert
quickli
higher
moi
natur
select
act
effici
larger
popul
size
tabl
biochem
studi
exonaa
intermedi
revert
valuabl
determin
whether
differ
intermedi
revert
defin
structur
kinet
featur
catalysi
final
studi
suggest
compensatori
mutat
identifi
longterm
passag
could
use
stabil
exonaa
genotyp
particular
highfidel
could
reduc
probabl
revers
reduc
mutat
sampl
within
motif
render
mhv
genom
inhospit
wtexond
togeth
studi
argu
experiment
evolut
gener
reagent
defin
critic
interact
involv
cov
replic
identifi
new
strategi
stabil
attenu
cov
delay
brain
tumor
cell
babi
hamster
kidney
cell
express
mhv
receptor
bhkr
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
serum
hyclon
fetal
clone
ii
ge
healthcar
fetal
bovin
serum
invitrogen
uml
penicillin
streptomycin
gibco
amphotericin
b
corn
bhkr
cell
supplement
mgml
select
antibiot
gibco
infecti
clone
murin
hepat
viru
strain
genbank
access
number
use
templat
recombin
virus
viru
sampl
serial
dilut
inocul
subconflu
cell
monolay
either
format
cell
overlaid
agar
dmem
incub
overnight
plate
fix
formaldehyd
agar
plug
remov
number
plaqu
per
well
count
hand
use
calcul
titer
dbt
cell
infect
serial
dilut
viru
overlaid
agar
dmem
singl
plaqu
isol
glass
pasteur
pipett
resuspend
phosphatebuff
salin
pb
contain
calcium
magnesium
inocul
onto
fresh
dbt
cell
process
complet
three
time
experiment
stock
gener
sitedirect
mutagenesi
mhv
genom
fragment
perform
use
roundthehorn
pcr
origin
describ
ho
et
al
briefli
adjac
primer
contain
mutat
interest
use
polynucleotid
kinas
neb
use
buffer
dna
ligas
contain
atp
pcr
perform
plasmid
templat
use
highfidel
master
mix
neb
primer
final
concentr
nm
linear
amplif
product
purifi
use
promega
wizard
sv
gel
pcr
cleanup
system
promega
corpor
ligat
overnight
dna
ligas
neb
transform
chemic
compet
e
coli
labderiv
expans
liquid
cultur
mhv
segment
plasmid
sequenc
virus
construct
rescu
sequenc
describ
previous
experiment
stock
gener
infect
subconflu
flask
cell
moi
pfucel
flask
frozen
monolay
fulli
involv
approxim
h
postinfect
depend
variant
thaw
supernat
clarifi
centrifug
g
sorval
rc
plu
rotor
min
intermedi
revert
stock
gener
serumfre
dmem
process
describ
concentr
roughli
centrifug
g
use
amicon
centrifug
filter
unit
cutoff
emd
millipor
viru
titer
stock
determin
plaqu
assay
use
cell
describ
intermedi
revert
exonaa
passag
time
subconflu
cell
monolay
plate
estim
moi
either
pfucel
supernat
harvest
h
postinfect
moi
pfucel
respect
screen
wt
revers
plaqu
assay
least
three
wtlike
plaqu
sequenc
lineag
confirm
motif
revers
viral
replic
kinet
cell
determin
moi
pfucel
describ
previous
replic
synchron
incub
transfer
incub
supernat
harvest
titer
determin
plaqu
assay
subconflu
monolay
cell
plate
infect
indic
viru
moi
pfucel
supernat
harvest
h
postinfect
genom
rna
supernat
quantifi
use
onestep
revers
transcriptionquantit
rtpcr
rtqpcr
trizolextract
rna
describ
previous
briefli
genom
rna
detect
fam
black
hole
quencher
label
probe
target
biosearch
technolog
petaluma
ca
rna
copi
number
calcul
refer
rna
standard
deriv
mhv
fragment
sampl
plate
technic
duplic
minim
welltowel
variat
titer
determin
plaqu
assay
cell
specif
infect
calcul
number
pfu
per
supernat
genom
rna
copi
stock
solut
sigma
prepar
dimethyl
sulfoxid
dmso
sensit
assay
perform
plate
moi
pfucel
previous
describ
cell
incub
drug
min
prior
infect
supernat
harvest
h
postinfect
titer
determin
plaqu
assay
exonaarefer
wtexonderefer
virus
mark
seven
consecut
silent
mutat
within
wild
type
refer
roundthehorn
pcr
describ
competit
perform
triplic
cell
plate
plate
densiti
cell
per
well
h
prior
infect
cell
infect
total
moi
pfucel
moi
pfucel
competitor
refer
viru
supernat
harvest
h
postinfect
experi
exonaarefer
wtexonderefer
respect
passag
four
time
titer
sampl
determin
passag
maintain
total
moi
pfucel
rna
extract
supernat
use
qiaamp
viru
qiacub
ht
kit
qiacub
ht
system
qiagen
rna
sampl
analyz
onestep
rtqpcr
two
sybr
green
assay
refer
virus
detect
forward
primer
ssqpcrsilf
nm
final
concentr
revers
primer
nm
final
concentr
competitor
detect
forward
primer
ssqpcrwtf
nm
final
concentr
revers
primer
nm
final
concentr
rna
sampl
dilut
prior
rtqpcr
power
sybr
green
rnatoct
kit
appli
biosystem
accord
manufactur
protocol
duplic
well
averag
valu
exclud
subsequ
analysi
duplic
well
differ
threshold
cycl
ct
rel
abund
competitor
refer
determin
subtract
ct
valu
competitor
ct
competitor
ct
refer
convert
reflect
fold
chang
ratio
ct
competitor
plot
passag
number
chang
ie
slope
linear
regress
rel
fit
note
regress
fit
slight
deviat
ratio
input
skew
slope
graphpad
prism
version
la
jolla
ca
use
perform
statist
test
comparison
mark
within
figur
legend
perform
mani
case
data
normal
level
untreat
control
perform
use
graphpad
prism
version
number
replic
sampl
indic
within
figur
legend
